Issuance for next week falls to an estimated $5.151 billion, with $3.959 billion of negotiated deals and $1.193 billion of ...

Nick Leeson went from being a symbol of everything that is wrong with financial markets to investigating the kind of misconduct he became famous for.

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Twilio ( NYSE: TWLO) boosted investor confidence after it released preliminary fourth quarter 2024 results and a multi-year ...

In a report released today, Marcus Diebel from J.P. Morgan maintained a Buy rating on Prosus (PROSF – Research Report), with a price target of ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

In a report released yesterday, Kenneth Goldman from J.P. Morgan maintained a Buy rating on Mondelez International (MDLZ – Research Report), ...

Archer-Daniels-Midland (NYSE:ADM – Get Free Report) had its price target lowered by research analysts at Barclays from $56.00 to $50.00 in a research note issued to investors on Tuesday,Benzinga ...

Ameren (NYSE:AEE – Get Free Report) was upgraded by research analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Tuesday, Marketbeat reports. The ...

Apple Inc. (NASDAQ:AAPL), the tech giant known for its innovative consumer electronics and services, is facing a complex ...

Shares of streaming giant Netflix (NFLX) soared as much as 15%, hitting an all-time high of $999 on Wednesday after it ...